Spyre Therapeutics, Inc.(SYRE)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Spyre Therapeutics, Inc. (SYRE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SYRE is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of SYRE by reported 13-F value include FMR, BlackRock, PERCEPTIVE ADVISORS, based on the most recent SEC filings. SYRE trades on the Nasdaq exchange and files with the SEC under CIK 1636282. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SYRE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Spyre Therapeutics, Inc. directly from SEC EDGAR.
Net Income
$-36.2M
SYRE key financials by period
Spyre Therapeutics, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2023
10-K/A
$886.0K
$-338.8M
—
FY 2022
10-K/A
$2.3M
$-83.8M
—
FY 2021
10-K/A
$18.7M
$-65.8M
—
FY 2018
10-K
$3.9M
$-44.3M
—
FY 2017
10-K
$5.2M
$-27.2M
—
FY 2016
10-K
$4.6M
$-21.7M
—
Institutions holding SYRE
Institutional investors reporting a position in Spyre Therapeutics, Inc. on SEC Form 13F.
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
